ALNYLAM PHARMACEUTICALS INC

CUSIP: 02043QAB3 Class: NOTE 1.000% 9/1

CAMDEN ASSET MANAGEMENT L P /CA's Holding History (CIK: 0000903944)

Note: Option positions (PUT/CALL) are excluded.

Q2 2024
Shares 3,000,000 Value ($000) $3,233 Avg Close — Range —
Q1 2024
Shares 3,000,000 Value ($000) $2,820 Avg Close — Range —
Q4 2023
Shares 2,500,000 Value ($000) $2,456 Avg Close — Range —